Short QT syndrome
Multiple genes have been implicated in the syndrome including KCNH2, KCNQ1, and KCNJ2. These genes code for cardiac ion channels.
Many patients with short QT syndrome receive cardioverter-defibrillator implantation. Antiarrhythmic drugs are sometimes used, but there is incomplete evidence for their effectiveness.
For more information, see OMIM.
I45.9 – Conduction disorder, unspecified
698272007 – Short QT syndrome
- Brugada syndrome
- Catecholaminergic polymorphic ventricular tachycardia
- Long QT syndrome
- Arrhythmogenic right ventricular dysplasia
- Sinus node dysfunction (eg, sinus bradycardia)
- Atrioventricular nodal block (first degree, second degree, third degree)
- Seizure disorder
- Neurocardiogenic syncope